Clinical trials
Terminated Recurrence trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Shanghai Junshi Bioscience Co., Ltd. | 2 |
| Axter Therapeutics (Beijing) Co., Ltd | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Chinese University of Hong Kong | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
| Guangzhou Bio-gene Technology Co., Ltd | 1 |
| Haifeng Qin | 1 |
| Hangzhou Cheetah Cell Therapeutics Co., Ltd | 1 |
| HitGen Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 25 |
| Leukemia, Myeloid, Acute | 4 |
| Multiple Myeloma | 3 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Atrial Fibrillation | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.